Essbio Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Essbio.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Water Utilities earnings growth | 0.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Investors Appear Satisfied With Essbio S.A.'s (SNSE:ESSBIO-C) Prospects As Shares Rocket 48%
May 21We Think That There Are More Issues For Essbio (SNSE:ESSBIO-C) Than Just Sluggish Earnings
Sep 15Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
May 30A Look At The Intrinsic Value Of Essbio S.A. (SNSE:ESSBIO-C)
Mar 29Should You Be Impressed By Essbio's (SNSE:ESSBIO-C) Returns on Capital?
Mar 09Here's Why Essbio (SNSE:ESSBIO-C) Has A Meaningful Debt Burden
Feb 15Should Essbio S.A. (SNSE:ESSBIO-C) Focus On Improving This Fundamental Metric?
Jan 04Has Essbio (SNSE:ESSBIO-C) Got What It Takes To Become A Multi-Bagger?
Dec 08Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?
Nov 17In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Essbio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 240,046 | 26,610 | 24,427 | 102,443 | N/A |
6/30/2024 | 237,547 | 29,781 | 29,218 | 106,169 | N/A |
3/31/2024 | 236,986 | 32,244 | 28,410 | 110,127 | N/A |
12/31/2023 | 233,768 | 29,684 | 29,485 | 108,050 | N/A |
9/30/2023 | 235,755 | 25,526 | 33,728 | 109,236 | N/A |
6/30/2023 | 231,955 | 15,635 | 30,957 | 105,102 | N/A |
3/31/2023 | 225,304 | 6,926 | 31,704 | 100,169 | N/A |
12/31/2022 | 218,855 | 7,149 | 30,772 | 94,961 | N/A |
9/30/2022 | 209,537 | 6,942 | 29,139 | 87,647 | N/A |
6/30/2022 | 203,861 | 14,469 | 32,460 | 87,908 | N/A |
3/31/2022 | 197,455 | 20,267 | 27,641 | 81,660 | N/A |
12/31/2021 | 188,898 | 18,466 | 27,048 | 77,548 | N/A |
9/30/2021 | 183,492 | 20,347 | 24,195 | 74,217 | N/A |
6/30/2021 | 178,327 | 19,195 | 21,982 | 70,875 | N/A |
3/31/2021 | 175,472 | 20,127 | 20,844 | 68,509 | N/A |
12/31/2020 | 173,777 | 20,786 | 17,133 | 69,802 | N/A |
9/30/2020 | 171,483 | 21,107 | 23,501 | 79,813 | N/A |
6/30/2020 | 170,230 | 21,046 | 22,723 | 75,818 | N/A |
3/31/2020 | 169,935 | 20,094 | 26,767 | 78,149 | N/A |
12/31/2019 | 169,193 | 20,508 | 31,720 | 77,855 | N/A |
9/30/2019 | 168,477 | 21,139 | 33,404 | 73,913 | N/A |
6/30/2019 | 167,463 | 20,702 | 32,451 | 74,630 | N/A |
3/31/2019 | 163,758 | 20,694 | 32,149 | 75,230 | N/A |
12/31/2018 | 159,272 | 19,259 | 32,255 | 68,611 | N/A |
9/30/2018 | 156,185 | 17,720 | 30,637 | 60,638 | N/A |
6/30/2018 | 153,701 | 19,387 | N/A | 56,947 | N/A |
3/31/2018 | 151,904 | 22,260 | N/A | 50,551 | N/A |
12/31/2017 | 149,564 | 25,132 | N/A | 50,057 | N/A |
9/30/2017 | 149,298 | 27,874 | N/A | 46,367 | N/A |
6/30/2017 | 148,070 | 26,884 | N/A | 47,472 | N/A |
3/31/2017 | 146,712 | 23,866 | N/A | 45,691 | N/A |
12/31/2016 | 147,731 | 23,351 | N/A | 44,956 | N/A |
9/30/2016 | 141,451 | 27,218 | N/A | 46,721 | N/A |
6/30/2016 | 141,813 | 26,833 | N/A | 47,332 | N/A |
3/31/2016 | 142,406 | 26,295 | N/A | 51,453 | N/A |
12/31/2015 | 140,122 | 25,176 | N/A | 53,715 | N/A |
9/30/2015 | 144,233 | 16,276 | N/A | 45,469 | N/A |
6/30/2015 | 141,447 | 16,099 | N/A | 43,728 | N/A |
3/31/2015 | 137,367 | 13,264 | N/A | 37,992 | N/A |
12/31/2014 | 134,834 | 68,059 | N/A | 36,220 | N/A |
9/30/2014 | 131,934 | 71,759 | N/A | 44,109 | N/A |
6/30/2014 | 130,316 | 71,774 | N/A | 41,601 | N/A |
3/31/2014 | 127,730 | 75,169 | N/A | 40,558 | N/A |
12/31/2013 | 122,736 | 16,798 | N/A | 40,785 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ESSBIO-C's forecast earnings growth is above the savings rate (5.5%).
Earnings vs Market: Insufficient data to determine if ESSBIO-C's earnings are forecast to grow faster than the CL market
High Growth Earnings: Insufficient data to determine if ESSBIO-C's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ESSBIO-C's revenue is forecast to grow faster than the CL market.
High Growth Revenue: Insufficient data to determine if ESSBIO-C's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ESSBIO-C's Return on Equity is forecast to be high in 3 years time